Since 2014
The market for hospital medicine in Denmark
Nordic Journal of Health Economics
View Archive Info| Field | Value | |
| Title |
The market for hospital medicine in Denmark
|
|
| Creator |
Hostenkamp, Gisela; University of Southern Denmark
|
|
| Subject |
Pharmaceuticals; Management; Pricing
Pharmaceuticals; Hospital; Procurement; Denmark; Tendering;Pricing |
|
| Description |
Pharmaceutical expenditure growth has outpaced GDP and healthcare expenditure growth rates in Denmark as in most OECD countries for the last decade. A major part of this increase was due to high growth rates in specialist areas that are typically located in hospital settings. Yet the market for hospital medicines and their procurement are still poorly understood. The present paper characterises the market for hospital medicines in Denmark in terms of its organisation and developments between 2005 and 2009. In Denmark hospital medicines are publicly financed and procurement is centrally organised. 98% of all medicines administered at Danish public hospitals are purchased through a public procurement agency by means of public tenders. Using data on actual contract prices we decompose pharmaceutical expenditure growth into the contributions from newly introduced medicines, price and volume increases and use summary statistics to compare market performance in both sectors. The market for hospital medicine is more concentrated than the pharmaceutical retail sector and the share of generics and parallel imported products is significantly lower. Between 2005 and 2009 expenditures for hospital medicines more than doubled -accounting for almost 40% of the total Danish pharmaceutical market in 2009. Price increases however - although positive and higher than in the pharmaceutical retail sector - were only moderate. The majority of the expenditure growth was due to an increase in utilisation and the introduction of new medicines in the hospital sector. Centralised tendering may therefore have important implications for competition and industry structure in the long run.
|
|
| Publisher |
University of Oslo
|
|
| Contributor |
The study was financially supported by AMGROS the Danish public procurement agency for hospital medicines
|
|
| Date |
2011-11-24
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion Peer-reviewed Article |
|
| Format |
application/pdf
|
|
| Identifier |
https://www.journals.uio.no/index.php/NJHE/article/view/175
10.5617/njhe.175 |
|
| Source |
Nordic Journal of Health Economics; Vol 1, No 1 (2012): Nordic Journal of Health Economics
1892-9710 1892-9729 |
|
| Language |
eng
|
|
| Relation |
https://www.journals.uio.no/index.php/NJHE/article/view/175/246
|
|
| Rights |
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
|
|